Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Certified by Founder
Lodge
CREATE Medicines
start up
United States
- Cambridge, Massachusetts
- 14/05/2026
- Series B
- $122,000,000
CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming. Its proprietary mRNA-LNP platform directly programs immune cells inside the body to deliver scalable, repeat-dose, off-the-shelf immunotherapies. With proven human validation and next-generation RNA technology, CREATE is advancing a pipeline of in vivo CAR therapies to transform outcomes in cancer, autoimmunity, and fibrosis.
- Industry Biotechnology
- Website https://createmedicines.com/
- LinkedIn https://www.linkedin.com/company/createmedicines/
Related People
Daniel G.Founder
United States -
Greater Boston
Dr Getts is a repeat inventor, company co-founder and builder. He is currently the Chief Executive Officer & co-founder of Myeloid Therapeutics Inc .
Origin Lab | $8,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)